Madlen Reschke

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

Leonardo R. Brandão, Matteo Luciani, Lisa Bomgaars et al. · The Lancet Haematology · 2020 · 149 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +12

Comparison of Three Patent Foramen Ovale Closure Devices in a Randomized Trial (Amplatzer Versus CardioSEAL-STARflex Versus Helex Occluder)

Margaret Taaffe, Evelyn Fischer, Andreas Baranowski et al. · The American Journal of Cardiology · 2008 · 142 citations

Medicine, Neurosurgery, Surgery +6

Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG)

Sabine Dittner‐Moormann, Madlen Reschke, Floor Abbink et al. · Pediatric Blood & Cancer · 2021 · 31 citations · Full text

Medicine, Oncology, Ophthalmology +13

Percutaneous Closure of the Left Atrial Appendage

S. Ostermayer, Madlen Reschke, Kai Billinger et al. · Journal of Interventional Cardiology · 2003 · 22 citations

Medicine, Cardiology, Surgery +13

Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria

Madlen Reschke, Eva Biewald, L Bronstein et al. · Cancers · 2021 · 15 citations · Full text

Medicine, Oncology, Pediatrics +17